San Antonio's University Hospital is one of the first hospitals to use a device called DyeVert Plus. Bluetooth technology embedded in the syringe uses wireless transmission to track exactly how much dye is used for each image. Tests of the new device show it can reduce the amount of dye used in heart procedures on kidney patients by as much as 40 percent.
http://ospreymed.com/wp-content/uploads/2017/06/tpr-dyevert.jpg600800Rob Coleman/wp-content/uploads/2017/04/osprey-logo-224w.pngRob Coleman2017-06-08 12:00:402017-07-05 20:31:19Cutting Down on Dye May Make Heart Procedures Safer for Kidney Patients
Osprey Medical today announced that it has received US FDA 510(k) clearance for its advanced DyeVert™ PLUS Contrast Reduction System. This new platform augments Osprey's current technology with the capability to actively manage dye administration during coronary interventions.
http://ospreymed.com/wp-content/uploads/2017/04/DyeVert-PLUS-System.jpg733813Rob Coleman/wp-content/uploads/2017/04/osprey-logo-224w.pngRob Coleman2017-03-09 01:40:312017-07-05 20:13:10Osprey Medical Receives US FDA Clearance for DyeVert™ Plus
Analyst Coverage Disclaimer
Please note that any opinions, esimates or forecasts regarding Osprey Medical's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Osprey Medical or its management. Osprey Medical does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Osprey Medical cannot guarantee its accuracy.